Category: NMO (NMOSD/Devics)

Neuromyelitis (NMO) & MOG with MS Specialist Dr. Carraro

Part 2 of our Optic Neuritis discussion with Dr. Carraro dives into Neuromyelitis Optica (NMO) and MOG (Myelin Oligodendrocyte Glycoprotein…

Stuart Schlossman

Featured image for “MS and co-morbid autoimmunity”

MS and co-morbid autoimmunity

In my experience, the most common co-morbid autoimmune disease in people with MS, outside of thyroid disease post-alemtuzumab, is MS-associated…

Stuart Schlossman

MS vs NMO Attacks: What You Need To Know

Click Image to listen to this video…

Stuart Schlossman

The MS Views and News Learning Channel, Presents: THE 2023 MS SYMPOSIUM – watch these educational videos with MS Neurologists Boster, Rosenthal, Steingo and more

  PLAYING 2023 MS Symposium (Part 1 of 5) – LIVING WELL with MS, Pain Management, Biomarkers and More 40:26…

Stuart Schlossman

High-Intensity Gait Training in an Individual With Neuromyelitis Optica and Research Recommendations for Individuals With Multiple Sclerosis

  Abstract Background: Neuromyelitis optica (NMO), similar to multiple sclerosis (MS), is an autoimmune disorder affecting the central nervous system.…

Stuart Schlossman

Autonomic Symptom Burden and Decreased Quality of Life Among Patients With MS and NMOSD

  Researchers in Serbia identified link between autonomic symptom burden and quality of life. Recently published findings in the journal Multiple…

Stuart Schlossman

Why Disability Strikes People With MS

  In the past multiple sclerosis (MS) was thought to primarily affect whites. However, studies have shown a higher incidence…

Stuart Schlossman

Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD

 Late-breaking results from Phase III trial of Ocrevus (ocrelizumab) subcutaneous injection and Phase II trial of BTK inhibitor fenebrutinib in…

Stuart Schlossman

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

  Abstract Objective:  To evaluate clinical features among patients with neuromyelitis optica spectrum disorders (NMOSD) who have myelin oligodendrocyte glycoprotein…

Stuart Schlossman

Patients suffering from neuro-inflammatory diseases such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) remain vulnerable to COVID-19.

Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and…

Stuart Schlossman

Categories

Latest Blog Posts